Abstract
Background: Pelvic inflammatory disease (PID) is a public health problem that demands rapid diagnosis and treatment and may severely impair female reproductive health.
Objective: To analyze anamnestic information, laboratory findings, and clinical and microbiological features of patients with severe acute PID that underwent a surgical procedure.
Methods: This retrospective study enrolled 97 cases that were surgically treated in the Department of Obstetrics and Gynecology, University Hospital „ Sveti Duh“ between 2009 and 2019.
Results: Most women were within the age group 35-44 (38.14%). Lower abdominal pain was the most common symptom (92.78%). Compared to intraoperatively confirmed PID, C-reactive protein (CRP) yielded the highest sensitivity (88.10%) while cervical motion tenderness possessed the highest specificity (53.85%). The tubo-ovarian abscess was detected in 35.05% of intraoperative specimens, mainly occurring in women between 45-54 years (p = 0.017) and absent between 15-24 (p = 0.012) and 25-34 years (p = 0.049). The length of hospital stay was influenced by the number of symptoms (ρ = 0.316, p = 0.002), admission CRP levels (ρ = 0.620, P < 0.001), and admission body temperature (ρ = 0.386, p < 0.001). Out of 59.30% of positive cultures, one pathogen was isolated in 70.59%, mainly Escherichia coli (41.18%). Admission CRP levels impacted the efficacy of microbiologic isolation (p = 0.001). The empirical treatment was mostly based on the clindamycin/gentamicin combination (51.72%).
Conclusion: Severe clinical picture that requires surgical treatment can be expected in women >35 years. Longer hospital stay was associated with more symptoms, higher CRP, and temperature values on admission. It is important to have a low threshold for diagnosis and to consider both aerobic and anaerobic pathogens when selecting antibiotic treatment.
Graphical Abstract
[1]
Njavro, B.; Njavro, L.; Grbavac, M. Minilaparoscopy in the diagnosis of pelvic inflammatory disease (PID). Med. Jadert., 2012, 42(1-2), 65-71.
[2]
Ciglar, S. Infections of upper female genital system. In: Ginekologija; Šimunić, V., Ed.; Ljevak: Zagreb, 2001; pp. 259-268.
[3]
Bartlett, E.C.; Levison, W.B.; Munday, P.E. Pelvic inflammatory disease. BMJ, 2013, 346, f3189.
[http://dx.doi.org/10.1136/bmj.f3189] [PMID: 23704128]
[http://dx.doi.org/10.1136/bmj.f3189] [PMID: 23704128]
[4]
Kuzman, M.; Znaor, A. Public health importance of urogenital infections and sexually transmitted infections. Medicus, 2012, 21(1_UGI)
[5]
Menezes, M.L.B.; Giraldo, P.C.; Linhares, I.M.; Boldrini, N.A.T.; Aragón, M.G. Brazilian protocol for sexually transmitted infections, 2020: pelvic inflammatory disease. Rev. Soc. Bras. Med. Trop., 2021, 54(Suppl. 1), e2020602.
[6]
Centers for Disease Control and Prevention. Pelvic Inflammatory Disease (PID) - 2015 STD Treatment Guidelines. cdc.gov/std/tg2015/pid.htm (Accessed January 17, 2021).
[7]
Gray-Swain, M.R.; Peipert, J.F. Pelvic inflammatory disease in adolescents. Curr. Opin. Obstet. Gynecol., 2006, 18(5), 503-510.
[http://dx.doi.org/10.1097/01.gco.0000242952.87125.69] [PMID: 16932044]
[http://dx.doi.org/10.1097/01.gco.0000242952.87125.69] [PMID: 16932044]
[8]
Mitchell, C.; Prabhu, M. Pelvic inflammatory disease: Current concepts in pathogenesis, diagnosis and treatment. Infect. Dis. Clin. North Am., 2013, 27(4), 793-809.
[http://dx.doi.org/10.1016/j.idc.2013.08.004] [PMID: 24275271]
[http://dx.doi.org/10.1016/j.idc.2013.08.004] [PMID: 24275271]
[10]
Sabbatucci, M.; Salfa, M.C.; Regine, V.; Pezzotti, P.; Suligoi, B. Estimated burden of Chlamydia trachomatis female infection and consequent severe pelvic inflammatory disease, Italy, 2005-2016. Ann. Ist. Super. Sanita, 2019, 55(3), 217-223.
[PMID: 31553313]
[PMID: 31553313]
[11]
Shikino, K.; Ikusaka, M. Fitz-Hugh-Curtis syndrome. BMJ Case Rep., 2019, 12(2), e229326.
[http://dx.doi.org/10.1136/bcr-2019-229326] [PMID: 30765452]
[http://dx.doi.org/10.1136/bcr-2019-229326] [PMID: 30765452]
[12]
Perine, P.L.; Handsfield, H.H.; Holmes, K.K.; Blount, J.H. Epidemiology of the sexually transmitted diseases. Annu. Rev. Public Health, 1985, 6(1), 85-106.
[http://dx.doi.org/10.1146/annurev.pu.06.050185.000505] [PMID: 3873248]
[http://dx.doi.org/10.1146/annurev.pu.06.050185.000505] [PMID: 3873248]
[13]
Karelović, D.; Skerlev, M. Pelvic inflammatory disease. In: Infections in gynecology and perinatology; Karelović, D., Ed.; Medicinska naklada: Zagreb, 2012; pp. 234-242.
[14]
Lobo, R.A.; Gershenson, D.M.; Lentz, G.M.; Valea, F.A., Eds.; Comprehensive Gynecology, 7th ed; Elsevier: Philadelphia, 2017.
[15]
Cliffe, S.J.; Tabrizi, S.; Sullivan, E.A. Chlamydia in the Pacific region, the silent epidemic. Sex. Transm. Dis., 2008, 35(9), 801-806.
[http://dx.doi.org/10.1097/OLQ.0b013e318175d885] [PMID: 18580823]
[http://dx.doi.org/10.1097/OLQ.0b013e318175d885] [PMID: 18580823]
[16]
DeSapri, K.A.T.; Christmas, M.M. Pelvic Inflammatory Disease Clinical Presentation. emedicine.medscape.com/article/256448-clinical#b1 (Accessed January 05, 2021).
[18]
Jamieson, D.J.; Duerr, A.; Macasaet, M.A.; Peterson, H.B.; Hillis, S.D. Risk factors for a complicated clinical course among women hospitalized with pelvic inflammatory disease. Infect. Dis. Obstet. Gynecol., 2000, 8(2), 88-93.
[http://dx.doi.org/10.1155/S1064744900000077] [PMID: 10805363]
[http://dx.doi.org/10.1155/S1064744900000077] [PMID: 10805363]
[19]
Schindlbeck, C.; Dziura, D.; Mylonas, I. Diagnosis of pelvic inflammatory disease (PID): Intra-operative findings and comparison of vaginal and intra-abdominal cultures. Arch. Gynecol. Obstet., 2014, 289(6), 1263-1269.
[http://dx.doi.org/10.1007/s00404-014-3150-7] [PMID: 24474636]
[http://dx.doi.org/10.1007/s00404-014-3150-7] [PMID: 24474636]
[20]
Morcos, R.; Frost, N.; Hnat, M.; Petrunak, A.; Caldito, G. Laparoscopic versus clinical diagnosis of acute pelvic inflammatory disease. J. Reprod. Med., 1993, 38(1), 53-56.
[PMID: 8441133]
[PMID: 8441133]
[21]
Gaitán, H.; Angel, E.; Diaz, R.; Parada, A.; Sanchez, L.; Vargas, C. Accuracy of five different diagnostic techniques in mild-to-moderate pelvic inflammatory disease. Infect. Dis. Obstet. Gynecol., 2002, 10(4), 171-180.
[http://dx.doi.org/10.1155/S1064744902000194] [PMID: 12648310]
[http://dx.doi.org/10.1155/S1064744902000194] [PMID: 12648310]
[22]
Lareau, S.M.; Beigi, R.H. Pelvic inflammatory disease and tubo-ovarian abscess. Infect. Dis. Clin. North Am., 2008, 22(4), 693-708.
[http://dx.doi.org/10.1016/j.idc.2008.05.008] [PMID: 18954759]
[http://dx.doi.org/10.1016/j.idc.2008.05.008] [PMID: 18954759]
[23]
Jaiyeoba, O.; Lazenby, G.; Soper, D.E. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev. Anti. Infect. Ther., 2011, 9(1), 61-70.
[http://dx.doi.org/10.1586/eri.10.156] [PMID: 21171878]
[http://dx.doi.org/10.1586/eri.10.156] [PMID: 21171878]
[24]
Lehtinen, M.; Laine, S.; Heinonen, P.K.; Teisala, K.; Miettinen, A.; Aine, R.; Punnonen, R.; Grönroos, P.; Paavonen, J. Serum C-reactive protein determination in acute pelvic inflammatory disease. Am. J. Obstet. Gynecol., 1986, 154(1), 158-159.
[http://dx.doi.org/10.1016/0002-9378(86)90419-9] [PMID: 2936244]
[http://dx.doi.org/10.1016/0002-9378(86)90419-9] [PMID: 2936244]
[25]
Hemilä, M.; Henriksson, L.; Ylikorkala, O. Serum CRP in the diagnosis and treatment of pelvic inflammatory disease. Arch. Gynecol. Obstet., 1987, 241(3), 177-182.
[http://dx.doi.org/10.1007/BF00931315] [PMID: 3435185]
[http://dx.doi.org/10.1007/BF00931315] [PMID: 3435185]
[26]
Chaparro, M.V.; Ghosh, S.; Nashed, A.; Poliak, A. Laparoscopy for the confirmation and prognostic evaluation of pelvic inflammatory disease. Int. J. Gynaecol. Obstet., 1978, 15(4), 307-309.
[http://dx.doi.org/10.1002/j.1879-3479.1977.tb00699.x] [PMID: 25803]
[http://dx.doi.org/10.1002/j.1879-3479.1977.tb00699.x] [PMID: 25803]
[27]
Jacobson, L.; Weström, L. Objectivized diagnosis of acute pelvic inflammatory disease. Am. J. Obstet. Gynecol., 1969, 105(7), 1088-1098.
[http://dx.doi.org/10.1016/0002-9378(69)90132-X] [PMID: 4242830]
[http://dx.doi.org/10.1016/0002-9378(69)90132-X] [PMID: 4242830]
[28]
Landers, D.V.; Sweet, R.L., Eds.; Pelvic Inflammatory Disease, 1st ed; Springer-Verlag: New York, 1997.
[http://dx.doi.org/10.1007/978-1-4612-0671-2]
[http://dx.doi.org/10.1007/978-1-4612-0671-2]
[29]
Chan, Y.; Parchment, W.; Skurnick, J.H.; Goldsmith, L.; Apuzzio, J.J. Epidemiology and clinical outcome of patients hospitalized with pelvic inflammatory disease complicated by tubo-ovarian abscess. Infect. Dis. Obstet. Gynecol., 1995, 3(4), 135-139.
[http://dx.doi.org/10.1155/S1064744995000470] [PMID: 18476036]
[http://dx.doi.org/10.1155/S1064744995000470] [PMID: 18476036]
[30]
Bricou, A.; Batt, R.E.; Chapron, C. Peritoneal fluid flow influences anatomical distribution of endometriotic lesions: Why Sampson seems to be right. Eur. J. Obstet. Gynecol. Reprod. Biol., 2008, 138(2), 127-134.
[http://dx.doi.org/10.1016/j.ejogrb.2008.01.014] [PMID: 18336988]
[http://dx.doi.org/10.1016/j.ejogrb.2008.01.014] [PMID: 18336988]
[31]
Pelzer, E.S.; Willner, D.; Buttini, M.; Hafner, L.M.; Theodoropoulos, C.; Huygens, F. The fallopian tube microbiome: Implications for reproductive health. Oncotarget, 2018, 9(30), 21541-21551.
[http://dx.doi.org/10.18632/oncotarget.25059] [PMID: 29765558]
[http://dx.doi.org/10.18632/oncotarget.25059] [PMID: 29765558]
[32]
Brunham, R.C.; Gottlieb, S.L.; Paavonen, J. Pelvic inflammatory disease. N. Engl. J. Med., 2015, 372(21), 2039-2048.
[http://dx.doi.org/10.1056/NEJMra1411426] [PMID: 25992748]
[http://dx.doi.org/10.1056/NEJMra1411426] [PMID: 25992748]
[33]
McKinnon, A.; Black, A.Y.; Lortie, K.; Fleming, N.A. A case of adolescent pelvic inflammatory disease caused by a rare bacterium: Fusobacterium nucleatum. J. Pediatr. Adolesc. Gynecol., 2013, 26(6), e113-e115.
[http://dx.doi.org/10.1016/j.jpag.2013.02.008] [PMID: 23619431]
[http://dx.doi.org/10.1016/j.jpag.2013.02.008] [PMID: 23619431]
[34]
Wang, Y.; Zhang, Y.; Zhang, Q.; Chen, H.; Feng, Y. Characterization of pelvic and cervical microbiotas from patients with pelvic inflammatory disease. J. Med. Microbiol., 2018, 67(10), 1519-1526.
[http://dx.doi.org/10.1099/jmm.0.000821] [PMID: 30113305]
[http://dx.doi.org/10.1099/jmm.0.000821] [PMID: 30113305]
[35]
Teisala, K. Endometrial microbial flora of hysterectomy specimens. Eur. J. Obstet. Gynecol. Reprod. Biol., 1987, 26(2), 151-155.
[http://dx.doi.org/10.1016/0028-2243(87)90050-5] [PMID: 3666272]
[http://dx.doi.org/10.1016/0028-2243(87)90050-5] [PMID: 3666272]
[36]
Sharma, H.; Tal, R.; Clark, N.; Segars, J. Microbiota and pelvic inflammatory disease. Semin. Reprod. Med., 2014, 32(1), 043-049.
[http://dx.doi.org/10.1055/s-0033-1361822] [PMID: 24390920]
[http://dx.doi.org/10.1055/s-0033-1361822] [PMID: 24390920]
[37]
Pelzer, E.S.; Allan, J.A. The isolation and identification of microorganisms in the reproductive environment: the potential impact on the IVF culture system and on IVF outcomes. J. Clin. Embryol., 2012, 15(3), 44-53.
[38]
Chen, C.; Song, X.; Wei, W.; Zhong, H.; Dai, J.; Lan, Z.; Li, F.; Yu, X.; Feng, Q.; Wang, Z.; Xie, H.; Chen, X.; Zeng, C.; Wen, B.; Zeng, L.; Du, H.; Tang, H.; Xu, C.; Xia, Y.; Xia, H.; Yang, H.; Wang, J.; Wang, J.; Madsen, L.; Brix, S.; Kristiansen, K.; Xu, X.; Li, J.; Wu, R.; Jia, H. The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat. Commun., 2017, 8(1), 875.
[http://dx.doi.org/10.1038/s41467-017-00901-0] [PMID: 29042534]
[http://dx.doi.org/10.1038/s41467-017-00901-0] [PMID: 29042534]
[39]
Lenz, J.D.; Dillard, J.P. Pathogenesis of Neisseria gonorrhoeae and the host defense in ascending infections of human fallopian tube. Front. Immunol. , 2018, 9, 2710.
[http://dx.doi.org/10.3389/fimmu.2018.02710] [PMID: 30524442]
[http://dx.doi.org/10.3389/fimmu.2018.02710] [PMID: 30524442]
[40]
Saini, S.; Gupta, N.; Aparna.; Batra, G.; Arora, D.R. Role of anaerobes in acute pelvic inflammatory disease. Indian J. Med. Microbiol., 2003, 21(3), 189-192.
[http://dx.doi.org/10.1016/S0255-0857(21)03071-1] [PMID: 17643017]
[http://dx.doi.org/10.1016/S0255-0857(21)03071-1] [PMID: 17643017]
[41]
Spencer, T.H.; Umeh, P.O.; Irokanulo, E.; Baba, M.M.; Spencer, B.B.; Umar, A.I.; Ardzard, S.A.; Oderinde, S.; Onoja, O. Bacterial isolates associated with pelvic inflammatory disease among female patients attending some hospitals in abuja, Nigeria. Afr. J. Infect. Dis., 2014, 8(1), 9-13.
[PMID: 24653811]
[PMID: 24653811]
[42]
Cohen, C.R.; Gravelle, L.; Symekher, S.; Waiyaki, P.; Stamm, W.E.; Kiehlbauch, J.A. Etiology of persistent tubo-ovarian abscess in Nairobi, Kenya. Infect. Dis. Obstet. Gynecol., 2003, 11(1), 45-51.
[http://dx.doi.org/10.1155/S1064744903000061] [PMID: 12839632]
[http://dx.doi.org/10.1155/S1064744903000061] [PMID: 12839632]
[43]
Verma, R.; Morrad, S.; Wirtz, J.J. Peptoniphilus asaccharolyticus-associated septic arthritis and osteomyelitis in a woman with osteoarthritis and diabetes mellitus. BMJ Case Rep., 2017, 2017, bcr-2017-219969.
[http://dx.doi.org/10.1136/bcr-2017-219969] [PMID: 28576913]
[http://dx.doi.org/10.1136/bcr-2017-219969] [PMID: 28576913]
[44]
Møller, B.R.; Kristiansen, F.V.; Thorsen, P.; Frost, L.; Mogensen, S.C. Sterility of the uterine cavity. Acta Obstet. Gynecol. Scand., 1995, 74(3), 216-219.
[http://dx.doi.org/10.3109/00016349509008942] [PMID: 7900526]
[http://dx.doi.org/10.3109/00016349509008942] [PMID: 7900526]
[45]
Soper, D.E. Pelvic inflammatory disease. Obstet. Gynecol., 2010, 116(2), 419-428.
[http://dx.doi.org/10.1097/AOG.0b013e3181e92c54] [PMID: 20664404]
[http://dx.doi.org/10.1097/AOG.0b013e3181e92c54] [PMID: 20664404]
[46]
Zhu, S.; Ballard, E.; Khalil, A.; Baartz, D.; Amoako, A.; Tanaka, K. Impact of early surgical management on tubo-ovarian abscesses. J. Obstet. Gynaecol., 2021, 41(7), 1097-1101.
[http://dx.doi.org/10.1080/01443615.2020.1821620] [PMID: 33249968]
[http://dx.doi.org/10.1080/01443615.2020.1821620] [PMID: 33249968]
[47]
Akselim, B.; Karaşin, S.S.; Demirci, A.; Üstünyurt, E. Can antibiotic treatment failure in tubo-ovarian abscess be predictable? Eur. J. Obstet. Gynecol. Reprod. Biol., 2021, 258, 253-257.
[http://dx.doi.org/10.1016/j.ejogrb.2021.01.011] [PMID: 33482459]
[http://dx.doi.org/10.1016/j.ejogrb.2021.01.011] [PMID: 33482459]
[48]
McNeeley, S.G.; Hendrix, S.L.; Mazzoni, M.M.; Kmak, D.C.; Ransom, S.B. Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am. J. Obstet. Gynecol., 1998, 178(6), 1272-1278.
[http://dx.doi.org/10.1016/S0002-9378(98)70333-3] [PMID: 9662312]
[http://dx.doi.org/10.1016/S0002-9378(98)70333-3] [PMID: 9662312]
[49]
Centers for Disease Control and Prevention. Pelvic Inflammatory Disease (PID) - 2021 STD Treatment Guidelines. cdc.gov/std/treatment-guidelines/pid.htm (Accessed March 09, 2023).
